Disclosures for "Treatment of Extracellular Antibody-mediated Autoimmune Encephalitis with Efgartigimod in Real-world Clinical Practice: Targeted Literature Review and Meta-analysis"
-
Mrs. De Belder has received personal compensation for serving as an employee of Argenx. Mrs. De Belder has or had stock in argenx.
-
Miss TAKTIKOU has received personal compensation for serving as an employee of IQVIA.
-
Dr. Jovanovic has received personal compensation for serving as an employee of IQVIA. Dr. Jovanovic has or had stock in IQVIA.
-
Ms. Papadimitriou has received personal compensation for serving as an employee of IQVIA.
-
Ignacio Demey, MD, PhD has received personal compensation for serving as an employee of IQVIA.
-
Dr. Ellor has received personal compensation for serving as an employee of argenx. Dr. Ellor has or had stock in argenx.
-
Mrs. De Ruyck has received personal compensation for serving as an employee of argenx. Mrs. De Ruyck has or had stock in argenx.